Home › Sickle Cell Disease › Texas › Houston
Pag-aaral pangklinika para sa Sickle Cell Disease sa Houston, TX
Isang pag-aaral para sa Sickle Cell Disease ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Nagre-recruitPhase 3
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Nagre-recruitPhase 3
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Nagre-recruitPhase 3
- UT Health University of Texas, Houston
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
- UT Health Science Center, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Nagre-recruitObservasyonal na pag-aaral
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Nagre-recruitPhase 3
- Baylor College of Medicine- Site Number : 8400055, Houston
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Nagre-recruitObservasyonal na pag-aaral
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
Nagre-recruitPhase 3
- Site # 8400004, Houston
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
Nagre-recruitPhase 2
- Baylor College of Medicine, Houston
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Nagre-recruitObservasyonal na pag-aaral
- University of Texas at Houston, Houston
Pag-aaral para sa Sickle Cell Disease sa ibang lungsod
- Atlanta, GA22 pag-aaral
- Washington, DC20 pag-aaral
- Memphis, TN18 pag-aaral
- Chicago, IL18 pag-aaral
- Philadelphia, PA15 pag-aaral
- Birmingham, AL14 pag-aaral
- New York City, NY13 pag-aaral
- St. Louis, MO12 pag-aaral
- Durham, NC10 pag-aaral
- Boston, MA10 pag-aaral
- Cincinnati, OH10 pag-aaral
- Pittsburgh, PA9 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)122 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer103 pag-aaral
- Kanser sa Ovary90 pag-aaral
- Acute Myeloid Leukemia86 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium69 pag-aaral
- Kanser sa Pancreas62 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.